Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [3]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN393540 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) (AA 288-388) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 288-388
- Isotype
- IgG
- Antibody clone number
- 1H4
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.
Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells.
Nonmotor symptoms in Parkin gene-related parkinsonism.
Occurrence of PARK2 mutations in a never-smoker population with Parkinson's disease in North India.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.
Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, Colcher A, Siderowf AD, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, Waters C, Fahn S, Ross BM, Cote LJ, Frucht S, Ford B, Alcalay RN, Rezak M, Novak K, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Neils GD, Verbitsky M, Kisselev S, Caccappolo E, Ottman R, Clark LN
Archives of neurology 2010 Jun;67(6):731-8
Archives of neurology 2010 Jun;67(6):731-8
Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells.
Suen DF, Narendra DP, Tanaka A, Manfredi G, Youle RJ
Proceedings of the National Academy of Sciences of the United States of America 2010 Jun 29;107(26):11835-40
Proceedings of the National Academy of Sciences of the United States of America 2010 Jun 29;107(26):11835-40
Nonmotor symptoms in Parkin gene-related parkinsonism.
Kägi G, Klein C, Wood NW, Schneider SA, Pramstaller PP, Tadic V, Quinn NP, van de Warrenburg BP, Bhatia KP
Movement disorders : official journal of the Movement Disorder Society 2010 Jul 15;25(9):1279-84
Movement disorders : official journal of the Movement Disorder Society 2010 Jul 15;25(9):1279-84
Occurrence of PARK2 mutations in a never-smoker population with Parkinson's disease in North India.
Prabhakar S, Vinish M, Das CP, Anand A
Neuroepidemiology 2010 Aug;35(2):152-9
Neuroepidemiology 2010 Aug;35(2):152-9
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
